Epidemiology of amyotrophic lateral sclerosis: an update of recent literature

E Longinetti, F Fang - Current opinion in neurology, 2019 - journals.lww.com
Provided with the increasing number of patients diagnosed with ALS and the improved
societal awareness of the disease, more resources should be allocated to the research and …

Prevalence of depression among amyotrophic lateral sclerosis (ALS) patients: A systematic review and meta-analysis

ME Heidari, J Nadali, A Parouhan, M Azarafraz… - Journal of affective …, 2021 - Elsevier
Background Amyotrophic lateral sclerosis (ALS) people have a high risk of severe mental
disorders, like depression, which impacts their function, quality of life, and mobility. However …

Decline of cognitive and behavioral functions in amyotrophic lateral sclerosis: a longitudinal study

E Bersano, MF Sarnelli, V Solara… - … Lateral Sclerosis and …, 2020 - Taylor & Francis
Background: A cognitive impairment, ranging from frontotemporal dementia (FTD) to milder
forms of dysexecutive or behavioral dysfunction, is detected in 30–50% of patients affected …

11C‐PK11195 PET–based molecular study of microglia activation in SOD1 amyotrophic lateral sclerosis

G Tondo, L Iaccarino, C Cerami… - Annals of Clinical …, 2020 - Wiley Online Library
Objective Neuroinflammation is considered a key driver for neurodegeneration in several
neurological diseases, including amyotrophic lateral sclerosis (ALS). SOD1 mutations cause …

Medications on hypertension, hyperlipidemia, diabetes, and risk of amyotrophic lateral sclerosis: A systematic review and meta-analysis

N Hu, H Ji - Neurological Sciences, 2022 - Springer
Objective To investigate the association between the use of common medications on
hypertension, hyperlipidemia, diabetes, and the risk of amyotrophic lateral sclerosis (ALS) …

[HTML][HTML] Cognitive dysfunction in amyotrophic lateral sclerosis: can we predict it?

F De Marchi, C Carrarini, A De Martino, L Diamanti… - Neurological …, 2021 - Springer
Conclusions To date, the research on humoral, radiological, neurophysiological, and
genetic correlates of neuropsychological alterations is at the early stage, and no conclusive …

Risk factors for cognitive impairment in amyotrophic lateral sclerosis: a systematic review and meta-analysis

T Yang, Y Hou, C Li, B Cao, Y Cheng, Q Wei… - Journal of Neurology …, 2021 - jnnp.bmj.com
Objective Cognitive impairment is a common, far-reaching but imperceptible manifestation in
patients with amyotrophic lateral sclerosis (ALS). We aimed to identify the risk factors for …

Developments in the assessment of non-motor disease progression in amyotrophic lateral sclerosis

A Chiò, A Canosa, A Calvo, C Moglia… - Expert Review of …, 2021 - Taylor & Francis
Introduction The burden of non-motor symptoms is a major determinant of quality of life and
outcome in amyotrophic lateral sclerosis (ALS) and has profound negative effect also on …

The classification and prediction of ferroptosis-related genes in ALS: a pilot study

Q Zhang, H Zhao, M Luo, X Cheng, Y Li, Q Li… - Frontiers in …, 2022 - frontiersin.org
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by
progressive muscle paralysis, which is followed by degeneration of motor neurons in the …

[HTML][HTML] Epidemiology of amyotrophic lateral sclerosis

MR Aktekin, H Uysal - Turk Noroloji Dergisi, 2020 - jag.journalagent.com
Amaç: İskemik serebrovasküler hastalık geçirmiş bireylerin akut döneminde karotis intima
media kalınlığı (tCIM) ile gövde kontrolü arasındaki ilişkinin incelenmesidir. Gereç ve …